| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.37B | +10.0% |
| Cost of Revenue | $949.7M | +10.3% |
| Gross Profit | $421.8M | +9.2% |
| R&D Expense | $11.4M | +1.8% |
| SG&A Expense | $189.7M | +13.5% |
| Operating Income | $212.4M | +26.4% |
| Interest Expense | $49.2M | +13.9% |
| Pre-tax Income | $145.6M | +18.2% |
| Income Tax | $29.6M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.8M | -76.5% |
| Accounts Receivable | $173.3M | +66.8% |
| Inventory | $199.8M | +69.5% |
| Current Assets | $421.3M | +8.6% |
| Total Assets | $707.2M | +1.5% |
| Current Liabilities | $143.5M | -42.9% |
| Long-term Debt | $929.5M | +93.2% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.0M | -90.7% |
| Investing Cash Flow | -$1.8M | -12.5% |
| Financing Cash Flow | -$135.0M | -11.7% |
| +236.4% |
| Net Income | $82.3M | +198.2% |
| EPS (Basic) | $0.88 | +25.7% |
| EPS (Diluted) | $0.88 | +25.7% |
| Total Liabilities |
| $1.08B |
| +42.2% |
| Stockholders' Equity | -$376.2M | +87.7% |